Immunotherapy Drugs Market: Global Industry Analysis, Trends, Market Size & Forecasts up to 2023 - PowerPoint PPT Presentation

Loading...

PPT – Immunotherapy Drugs Market: Global Industry Analysis, Trends, Market Size & Forecasts up to 2023 PowerPoint presentation | free to download - id: 896f98-ZjZlM



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

Immunotherapy Drugs Market: Global Industry Analysis, Trends, Market Size & Forecasts up to 2023

Description:

The report on Immunotherapy Drugs Market by product (monoclonal antibodies, checkpoint inhibitors, vaccines, inferon’s and others), by disease condition (cancer, infectious disease, autoimmune disease, and others) trends analysis and forecasts up to 2023 studies the market sizes, key trends and opportunities in the main geographies such as North America, Europe, Asia-Pacific, Rest of the World. According to the report the Global Immunotherapy Drugs Market is projected to grow at a CAGR between 13.5 % to 14.0% in terms of value over the period of 2017-2023. The growth in the world market is primarily driven by significant contribution by North America (Leading region) region to this market. – PowerPoint PPT presentation

Number of Views:4
Slides: 7
Provided by: bondallen78
Category: Other

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Immunotherapy Drugs Market: Global Industry Analysis, Trends, Market Size & Forecasts up to 2023


1
Immunotherapy Drugs Market Global Industry
Analysis, Trends, Market Size Forecasts up to
2023
2
The report on Immunotherapy Drugs Market by
product (monoclonal antibodies, checkpoint
inhibitors, vaccines, inferons and others), by
disease condition (cancer, infectious disease,
autoimmune disease, and others) trends analysis
and forecasts up to 2023 studies the market
sizes, key trends and opportunities in the main
geographies such as North America, Europe,
Asia-Pacific, Rest of the World. According to the
report the Global Immunotherapy Drugs Market is
projected to grow at a CAGR between 13.5 to
14.0 in terms of value over the period of
2017-2023. The growth in the world market is
primarily driven by significant contribution by
North America (Leading region) region to this
market. Get Sample Copy of this Report-
https//www.infiniumglobalresearch.com/Reports/Mak
eSampleRequest/312
Immunotherapy is a biological therapy, which
harnesses the ability of the immune system of a
human body for combating a disease or an
infection. Immunotherapy techniques either
involve stimulation of immune system to work
smarter against the attack of cancer cells or
induction of artificial immune system proteins or
some other immune system components to improve
the immunity. Immunotherapy is an alternative
treatment for multiple type of cancers such as
brain, bladder, breast, cervical, colorectal,
gastric, kidney, lymphoma, leukemia, lung,
ovarian, prostrate and melanoma. In the case of
cancer, immunotherapy helps in slowing or
stopping the cancer cells growth, stops spreading
of cancer to other regions of the body and
stimulates the immune system to destroy the
cancer cells effectively. Adoptive T-cell
transfer, adjuvant immunotherapy, checkpoint
inhibitors, cytokines, monoclonal antibodies,
therapeutic cancer vaccines and oncolytic virus
immunotherapy are some of the types of
immunotherapy. Immunotherapy is also termed as
3
living drug, as the t-cells from the patients are
re-engineered for creating special antigen
receptors. Moreover, immunotherapy is also
useful treatment for autoimmune disease, combined
immunodeficiency, inflammatory diseases and some
other biological infectious diseases. The global
immunotherapy market is driven by Increasing
number of patients with lifestyle related
illnesses and preference for targeted therapies,
which cause minimal side effects. Immunotherapy
is gaining importance as an alternative
frontline treatment for cancer patients, who are
averse to the serious side effects related to
the chemotherapy. Increasing number of cancer
patients, minimal side effects and increasing
awareness among patients are the major factors
that are expected to drive the growth of the
global immunotherapy drugs market during the
forecast period. The combination of an immunity
checkpoint inhibitor with common cold virus has
led to a better immune response among some
advanced melanoma patients. The undergoing
research programmes related to immunotherapy are
expected to yield new drugs and effective
treatments for multiple sclerosis, mesothelioma,
paralysis and other diseases during the forecast
period. High cost involved in the manufacturing
of immunotherapy drugs is a major challenge for
the major players in the market. The high cost
of the immunotherapy treatment and high
depreciation related to the product cycle are the
major restraints for the growth of the global
immunotherapy market. Emerging markets are
expected to provide opportunities for major
players in the global immunotherapy market to
expand, due to the increasing demand for
alternatives for conventional cancer treatments
that are very costly. Segments Covered The
report segments the global immunotherapy market
by product, disease condition and region. On the
basis of product, the market is segmented as
monoclonal antibodies, checkpoint inhibitors,
vaccines, inferons and others. Based on disease
condition, the market is segmented as cancer,
infectious disease, autoimmune disease, and
others. Cancer segment has the highest share in
the global immunotherapy drugs
4
market as a majority of the drugs available are
for various cancer treatments. Increasing demand
for monoclonal antibodies, due to its
effectiveness in dealing with specific cells or
areas with disease is expected to drive the
demand for immunotherapy drugs. Moreover,
effectiveness of monoclonal antibodies in other
therapies is expected to enhance the growth of
the global immunotherapy market significantly.
The increasing acceptance of low-cost
biosimilars of popular biological immunotherapy
drugs is also expected to drive the growth of
the global immunotherapy drugs market.
Furthermore, increasing number of patients with
autoimmune diseases is expected to drive demand
for immunotherapy drugs during the forecast
period. Make an Enquiry- https//www.infiniumglo
balresearch.com/Reports/MakeEnquiryRequest/312
Geographic Coverage and Analysis The report
provides regional analysis covering geographies
such as North America, Europe, Asia-Pacific, and
Rest of the World. North-American region is the
largest immunotherapy market in the world.
Increasing number of patients with autoimmune
diseases, infectious diseases and cancer drive
the demand for the immunotherapy drugs, as
reimbursement plans and insurance make various
therapies affordable for them and it drives the
growth of the North-American immunotherapy
market. The growing number of autoimmune disease
and cancer patients drives the growth of the
European immunotherapy market. Efficient research
development for developing new drugs and the
acceptance of biosimilar immunotherapy drugs are
expected to drive the growth of the European
immunotherapy drugs market during the forecast
period. The presence of large population,
increasing number of people with lifestyle
related illnesses and the increasing demand for
treatments with minimal side effects in countries
such as China, India, Indonesia and other
countries are expected to propel Asia-Pacific
region as the fastest growing immunotherapy drugs
market. The research and
5
development related to infectious diseases like
HIV is expected to provide positive outlook for
African immunotherapy market during the forecast
period. Moreover, the need for alternative
treatment for cancer, autoimmune, inflammatory
and other diseases in developing countries in
Africa is expected to provide growth
opportunities for the market players. Presence of
good healthcare facilities in Middle East is
expected to provide opportunities for the growth
of demand for immunotherapy drugs, if there is a
significant reduction in the prices during the
forecast period. Companies Profiled Hoffmann-La
Roche AG, Merck Co., Inc., Novartis
International AG, Johnson Johnson,
GlaxoSmithKline PLC, Amgen Inc, AstraZeneca
PLC, Bristol-Myers Squibb, Galena Biopharma,
Inovio Pharmaceuticals.
6
Click the Below Full Report Link- https//www.inf
iniumglobalresearch.com/healthcare_medical_devices
/immunotherapy_drugs_market
Report Highlights The report provides deep
insights on demand forecasts, market trends and
micro and macro indicators. In addition, this
report provides insights on the factors that are
driving and restraining the demand of
immunotherapy globally as well as regionally.
Moreover, IGR-Growth Matrix analysis given in the
report brings an insight on the investment areas
that existing or new market players can consider.
The report provides insights into the market
using analytical tools such as Porters five
forces analysis and DRO analysis of
immunotherapy. Moreover, the study highlights
current market trends and provides forecast from
2017 to 2023. We also have highlighted future
trends in the immunotherapy market that will
impact the demand during the forecast period.
Moreover, the competitive analysis given in each
regional market brings an insight on the market
share of the leading players. Additionally, the
analysis highlights rise and fall in the market
shares of the key players in the market. This
report will help manufacturers, suppliers and
distributors of the immunotherapy market to
understand the present and future trends in this
market and formulate their strategies
accordingly.
About PowerShow.com